← Eichor
Study identifier: NCT05327972 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

DEgenerative ROtator Cuff Disease and Botulinum TOXin

Condition: Degenerative Rotator Cuff Disease  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhasePhase 2
Planned participants60
Who can joinAll sexes, 41 Years to no upper limit
Healthy volunteersNo

About this study

The aim of the study is to assess the effectiveness of botulinum toxin in persistent shoulder pain due to degenerative rotator cuff disease.

This description comes directly from the study's public registry record.

Talk to the study team

Johann MD BEAUDREUIL, PHD  ·  +33(0) 1 49 95 63 08  ·  johann.beaudreuil@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Hôpital LARIBOISIEREParis, Paris, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05327972